a new "gliptin" for type 2 diabetes called Tradjenta (TRAD-gen-ta, linagliptin)

Reps will be promoting a new "gliptin" for type 2 diabetes called Tradjenta (TRAD-gen-ta, linagliptin).

Tradjenta is the latest "me too" drug to hit the market. Think of it as another Onglyza (saxagliptin) or Januvia (sitagliptin).

Tradjenta is almost the same as the others. It lowers blood sugar about the same as Januvia or Onglyza...and has similar side effects and risks.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote